Peter R. Jermain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter R. Jermain has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alona Muzikansky
Biostatistics Center, Massachusetts General Hospital, Boston, MA 02114, USA
2 shared publications - Anna N. Yaroslavsky
Advanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, USA
2 shared publications - Anna N. Yaroslavsky
Advanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA 01854, USA
2 shared publications - Tyler W. Iorizzo
Advanced Biophotonics Laboratory, University of Massachusetts Lowell, Lowell, MA 01854, USA
2 shared publications - Andrew H. Fischer
Department of Pathology, University of Massachusetts Memorial Health Care, Worcester, Massachusetts
1 shared publication Andrzej Niemierko
Massachusetts General Hospital
1 shared publication
Latest Publications
- 17 June 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (13)
Evaluation of robust central nervous system treatment planning on a compact, gantry-less proton therapy system
Objective: This study assessed the clinical feasibility of robust treatment planning for central nervous system (CNS) tumors using a gantry-less proton therapy configuration, with the goal of supporting adoption of compact proton systems that are more affordable and accessible. Approach: Treatment plans for CNS cases were created in RayStation with three configurations: a full-gantry with the patient in a supine position, and a fixed, horizontal beamline with the patient either in a supine or seated position. Robust optimization was used for each plan, accounting for ±2mm isotropic setup errors and ±3.5% range uncertainties. To simulate potential impact of slouch, anisotropic setup shifts (±2, ±3, ±4mm) in the superior-inferior direction were evaluated for treatments in the seated position. A radiation oncologist conducted a blind review of the gantry-based and gantry-less plans to determine the preferred option. Dose metrics and robustness were compared across the different configurations, and statistical analyses were performed to assess the significance of any differences. In total, there were 10 cases, 50 treatment plans, and 1,050 treatment course scenarios. Main Results: Results showed that proton pencil beam scanning plans using a fixed horizontal beamline can produce comparable dosimetric outcomes to those utilizing a full-gantry. All three configurations achieved the required target coverage, with hotspots generally within 3-5% of the prescribed dose. In 8 out of 10 cases, the target homogeneity index was lowest in a gantry-less configuration. The gantry-based and gantry-less plans demonstrated similar robustness against setup errors and range uncertainties, though target coverage was slightly more robust in certain gantry or gantry-less plans, depending on the specific case and treatment configuration. Significance: By integrating blinded radiation oncologist assessment with quantitative dosimetric analysis, this work shows that fixed, horizontal proton beamlines can deliver high-quality plans, supporting the initial clinical feasibility of compact proton therapy systems.
- 17 June 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (13)
Evaluation of robust central nervous system treatment planning on a compact, gantry-less proton therapy system
Objective: This study assessed the clinical feasibility of robust treatment planning for central nervous system (CNS) tumors using a gantry-less proton therapy configuration, with the goal of supporting adoption of compact proton systems that are more affordable and accessible. Approach: Treatment plans for CNS cases were created in RayStation with three configurations: a full-gantry with the patient in a supine position, and a fixed, horizontal beamline with the patient either in a supine or seated position. Robust optimization was used for each plan, accounting for ±2mm isotropic setup errors and ±3.5% range uncertainties. To simulate potential impact of slouch, anisotropic setup shifts (±2, ±3, ±4mm) in the superior-inferior direction were evaluated for treatments in the seated position. A radiation oncologist conducted a blind review of the gantry-based and gantry-less plans to determine the preferred option. Dose metrics and robustness were compared across the different configurations, and statistical analyses were performed to assess the significance of any differences. In total, there were 10 cases, 50 treatment plans, and 1,050 treatment course scenarios. Main Results: Results showed that proton pencil beam scanning plans using a fixed horizontal beamline can produce comparable dosimetric outcomes to those utilizing a full-gantry. All three configurations achieved the required target coverage, with hotspots generally within 3-5% of the prescribed dose. In 8 out of 10 cases, the target homogeneity index was lowest in a gantry-less configuration. The gantry-based and gantry-less plans demonstrated similar robustness against setup errors and range uncertainties, though target coverage was slightly more robust in certain gantry or gantry-less plans, depending on the specific case and treatment configuration. Significance: By integrating blinded radiation oncologist assessment with quantitative dosimetric analysis, this work shows that fixed, horizontal proton beamlines can deliver high-quality plans, supporting the initial clinical feasibility of compact proton therapy systems.
- Open Access
Translational Potential of Fluorescence Polarization for Breast Cancer Cytopathology
Breast cancer is the most common malignancy in women. The standard of care for diagnosis involves invasive core needle biopsy followed by time-consuming histopathological evaluation. A rapid, accurate, and minimally invasive method to diagnose breast cancer would be invaluable. Therefore, this clinical study investigated the fluorescence polarization (Fpol) of the cytological stain methylene blue (MB) for the quantitative detection of breast cancer in fine needle aspiration (FNA) specimens. Cancerous, benign, and normal cells were aspirated from excess breast tissues immediately following surgery. The cells were stained in aqueous MB solution (0.05 mg/mL) and imaged using multimodal confocal microscopy. The system provided MB Fpol and fluorescence emission images of the cells. Results from optical imaging were compared to clinical histopathology. In total, we imaged and analyzed 3808 cells from 44 breast FNAs. Fpol images displayed quantitative contrast between cancerous and noncancerous cells, whereas fluorescence emission images showed the morphological features comparable to cytology. Statistical analysis demonstrated that MB Fpol is significantly higher (p < 0.0001) in malignant vs. benign/normal cells. It also revealed a correlation between MB Fpol values and tumor grade. The results indicate that MB Fpol could provide a reliable, quantitative diagnostic marker for breast cancer at the cellular level.
Open AccessTranslational Potential of Fluorescence Polarization for Breast Cancer Cytopathology
Breast cancer is the most common malignancy in women. The standard of care for diagnosis involves invasive core needle biopsy followed by time-consuming histopathological evaluation. A rapid, accurate, and minimally invasive method to diagnose breast cancer would be invaluable. Therefore, this clinical study investigated the fluorescence polarization (Fpol) of the cytological stain methylene blue (MB) for the quantitative detection of breast cancer in fine needle aspiration (FNA) specimens. Cancerous, benign, and normal cells were aspirated from excess breast tissues immediately following surgery. The cells were stained in aqueous MB solution (0.05 mg/mL) and imaged using multimodal confocal microscopy. The system provided MB Fpol and fluorescence emission images of the cells. Results from optical imaging were compared to clinical histopathology. In total, we imaged and analyzed 3808 cells from 44 breast FNAs. Fpol images displayed quantitative contrast between cancerous and noncancerous cells, whereas fluorescence emission images showed the morphological features comparable to cytology. Statistical analysis demonstrated that MB Fpol is significantly higher (p < 0.0001) in malignant vs. benign/normal cells. It also revealed a correlation between MB Fpol values and tumor grade. The results indicate that MB Fpol could provide a reliable, quantitative diagnostic marker for breast cancer at the cellular level.
- Open Access
Design and Validation of a Handheld Optical Polarization Imager for Preoperative Delineation of Basal Cell Carcinoma
Background: Accurate removal of basal cell carcinoma (BCC) is challenging due to the subtle contrast between cancerous and normal skin. A method aiding with preoperative delineation of BCC margins would be valuable. The aim of this study was to implement and clinically validate a novel handheld optical polarization imaging (OPI) device for rapid, noninvasive, in vivo assessment of skin cancer margins. Methods: The handheld imager was designed, built, and tested. For clinical validation, 10 subjects with biopsy-confirmed BCC were imaged. Presumable cancer margins were marked by the study surgeon. The optical images were spectrally encoded to mitigate the impact of endogenous skin chromophores. The results of OPI and of the surgeon’s preoperative visual assessment were compared to clinical intraoperative histopathology. Results: As compared to the previous prototype, the handheld imager incorporates automated image processing and has 10-times shorter acquisition times. It is twice as light and provides twice as large a field of view. Clinical validation demonstrated that margin assessments using OPI were more accurate than visual assessment by the surgeon. The images were in good correlation with histology in 9 out of 10 cases. Conclusions: Handheld OPI could improve the outcomes of skin cancer treatments without impairing clinical workflows.
Open AccessDesign and Validation of a Handheld Optical Polarization Imager for Preoperative Delineation of Basal Cell Carcinoma
Background: Accurate removal of basal cell carcinoma (BCC) is challenging due to the subtle contrast between cancerous and normal skin. A method aiding with preoperative delineation of BCC margins would be valuable. The aim of this study was to implement and clinically validate a novel handheld optical polarization imaging (OPI) device for rapid, noninvasive, in vivo assessment of skin cancer margins. Methods: The handheld imager was designed, built, and tested. For clinical validation, 10 subjects with biopsy-confirmed BCC were imaged. Presumable cancer margins were marked by the study surgeon. The optical images were spectrally encoded to mitigate the impact of endogenous skin chromophores. The results of OPI and of the surgeon’s preoperative visual assessment were compared to clinical intraoperative histopathology. Results: As compared to the previous prototype, the handheld imager incorporates automated image processing and has 10-times shorter acquisition times. It is twice as light and provides twice as large a field of view. Clinical validation demonstrated that margin assessments using OPI were more accurate than visual assessment by the surgeon. The images were in good correlation with histology in 9 out of 10 cases. Conclusions: Handheld OPI could improve the outcomes of skin cancer treatments without impairing clinical workflows.
- Open Access
Fluorescence Polarization Imaging of Methylene Blue Facilitates Quantitative Detection of Thyroid Cancer in Single Cells
Background: Diagnostic accuracy of the standard of care fine-needle aspiration cytology (FNAC) remains a significant problem in thyroid oncology. Therefore, a robust and accurate method for reducing uncertainty of cytopathological evaluation would be invaluable. Methods: In this double-blind study, we employed fluorescence emission and quantitative fluorescence polarization (Fpol) confocal imaging for sorting thyroid cells into benign/malignant categories. Samples were collected from malignant tumors, benign nodules, and normal thyroid epithelial tissues. Results: A total of 32 samples, including 12 from cytologically indeterminate categories, were stained using aqueous methylene blue (MB) solution, imaged, and analyzed. Fluorescence emission images yielded diagnostically relevant information on cytomorphology. Significantly higher MB Fpol was measured in thyroid cancer as compared to benign and normal cells. The results obtained from 12 indeterminate samples revealed that MB Fpol accurately differentiated benign and malignant thyroid nodules. Conclusions: The developed imaging approach holds the potential to provide an accurate and objective biomarker for thyroid cancer, improve diagnostic accuracy of cytopathology, and decrease the number of lobectomy and near-total thyroidectomy procedures.
Open AccessFluorescence Polarization Imaging of Methylene Blue Facilitates Quantitative Detection of Thyroid Cancer in Single Cells
Background: Diagnostic accuracy of the standard of care fine-needle aspiration cytology (FNAC) remains a significant problem in thyroid oncology. Therefore, a robust and accurate method for reducing uncertainty of cytopathological evaluation would be invaluable. Methods: In this double-blind study, we employed fluorescence emission and quantitative fluorescence polarization (Fpol) confocal imaging for sorting thyroid cells into benign/malignant categories. Samples were collected from malignant tumors, benign nodules, and normal thyroid epithelial tissues. Results: A total of 32 samples, including 12 from cytologically indeterminate categories, were stained using aqueous methylene blue (MB) solution, imaged, and analyzed. Fluorescence emission images yielded diagnostically relevant information on cytomorphology. Significantly higher MB Fpol was measured in thyroid cancer as compared to benign and normal cells. The results obtained from 12 indeterminate samples revealed that MB Fpol accurately differentiated benign and malignant thyroid nodules. Conclusions: The developed imaging approach holds the potential to provide an accurate and objective biomarker for thyroid cancer, improve diagnostic accuracy of cytopathology, and decrease the number of lobectomy and near-total thyroidectomy procedures.
- Open Access
- 1 October 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (10) , 1994-2000.e1
Dual-Wavelength Optical Polarization Imaging for Detecting Skin Cancer Margins
- 1 October 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (10) , 1994-2000.e1
Open AccessDual-Wavelength Optical Polarization Imaging for Detecting Skin Cancer Margins